National Jewish Health
L

Tocilizumab in Systemic Sclerosis: FocuSSed Trial Study Discussion

By National Jewish Health FEATURING Liudmila Kastsianok, Rebecca Keith
By National Jewish Health FEATURING Liudmila Kastsianok, Rebecca Keith
0 views
September 23, 2021
Liudmila Kastsianok, MD and Rebecca Keith, MD of National Jewish Health discuss the article “Tocilizumab ...
read more ↘
Comments 0
Login to view comments. Click here to Login

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Recommended

AUTOPLAY
51:53
Shaheen Islam

ATS 2022: Approach to Lung Nodules in 2022

16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
19:21
CHEST 2022 Coverage

A Radiologist's Approach to Subsolid Pulmonary Nodules

Feat. A. Guttentag
28:18
UCLA Health

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Feat. J. Belperio
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
52:53
University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith
21:34
CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni
25:48
University of Colorado Department of Medicine

Sarcoidosis: Diagnosis and Management

Feat. N. Held
09:19
Toby Maher

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

40:52
RheumNow

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

Feat. J. Sparks, J. Cush
34:08
Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells
12:52
The France Foundation

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

Feat. V. Khangoora
25:25
Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert
16:54
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Lymphangioleiomyomatosis: A Clinical Overview

Feat. F. Mccormack
07:57
Temple Lung Center

Clinical Trials for Pulmonary Fibrotic Diseases

Feat. G. Criner
17:49
NYU Langone

Antifibrotic Therapy for Stage 4 Pulmonary Sarcoidosis

Feat. M. A Judson
31:36
Keck School of Medicine of USC

Pulmonary Manifestations of SLE: An Update

Feat. F. Quismorio
47:30
West Virginia State Rheumatology Society

Myositis ILD: An Update

Feat. R. Aggarwal
29:59
CHEST 2023 Insights

CHEST 2023 Insights: Interstitial Lung Abnormality (ILA)

Feat. S. Raoof